San Antonio — Kiromic, a Houston-based biotech company with artificial intelligence software that it’s using to develop two experimental cancer immunotherapies, may move to San Antonio—if it gets $200,000 from a city-operated economic development group.
The money isn’t free. In exchange,... Read more »
In two and a half weeks, Xconomy will host our seventh annual Napa Summit: The Xconomy Retreat on Technology, Jobs, and Growth. In the heart of California’s wine country, it is our most exclusive, intimate, and unique conference. There are... Read more »
[Updated 5/24/18, 3:16 pm. See below.] The dominoes are starting to fall in the wake of a U.S. Supreme Court decision this month that opened the door for states to legalize sports gambling.
FanDuel has agreed to be acquired... Read more »
Fishidy, a startup that has developed map-based tools to help fishing enthusiasts document and share information, was acquired in April by Flir Systems, a developer of thermal imaging cameras and sensors. That’s according to Don Layden, an operating partner... Read more »
Bloom Science, a biotech founded to advance a new class of microbe-based therapeutics for neurological disorders, is making its debut today with the publication of research that suggests certain bacteria in the gut could be used to manage epileptic seizures.... Read more »
Renaissance Venture Capital Fund, an Ann Arbor, MI-based fund-of-funds, has racked up another $81 million after closing its third capital round last week.
The firm has raised a total of $205 million since it was established in 2008, says CEO and... Read more »
The IPO window remains wide open for biotechs. Two more, Kiniksa Pharmaceuticals and Scholar Rock, make their Wall Street debuts this morning having raised $227 million combined in their IPOs last night.
Kiniksa exceeded its funding goals. The Lexington, MA, company... Read more »
Growing up in China, Zhi Hong saw the healthcare challenges of his homeland firsthand. Despite the country’s economic strides, life science innovation there lags advances made in the West, he says. The GlaxoSmithKline veteran now wants to use his experience to... Read more »
More money continues to flow into startups seeking to harness the massive amount of data available in healthcare using artificial intelligence and machine learning. This time, GV, the venture capital arm of Google parent Alphabet, is adding about $7 million to... Read more »
Bike sharing is the new ride hailing.
Similar to what has played out with Uber, Lyft, Didi Chuxing, and other private car-hailing app companies, investors are pumping hundreds of millions of dollars into bike-sharing startups around the world racing to be... Read more »
[Updated 5/23/18, 9:40 am. See below.] Jeff Glass is back in the CEO chair at a startup, and this time he’s venturing into one of the oldest and, at the moment, hottest industries: real estate.
Glass is an entrepreneur... Read more »
The rapidly changing treatment landscape for lung cancer could soon change again.
This morning, Merck (NYSE: MRK) announced that a Phase 3 study called Keynote-407 has succeeded. The trial tested a combination of its immunotherapy pembrolizumab (Keytruda) and chemotherapy... Read more »
We’ve just posted the agenda for New York Biotech: Bringing Back the Expats, which is set for June 21 at Riverpark at the Alexandria Center in New York.
We are bringing together a few biopharma leaders who are ex-New Yorkers... Read more »